Inspire Medical Systems Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	915.25	911.98	802.8	624.8	407.86	233.39
Revenue Growth (YoY)	8.94%	13.60%	28.49%	53.19%	74.75%	102.28%
Cost of Revenue	130.19	133.23	122.99	96.58	66.12	33.28
Gross Profit	785.06	778.76	679.82	528.22	341.74	200.12
Selling, General & Admin	632.55	624.64	529.61	451.96	320.69	202.62
Research & Development	101.19	103.17	114.13	116.54	68.65	37.35
Total Operating Expenses	733.74	727.8	643.74	568.49	389.33	239.97
Operating Income	51.32	50.95	36.08	-40.27	-47.59	-39.85
Interest Income	16.21	17.54	23.25	20.56	5.05	0.13
Interest Expense	-0.14	-0.14	-0.02	-	-1.68	-2.13
Other Non-Operating Income (Expense)	3.01	2.66	0.86	0.2	0.05	0.12
Total Non-Operating Income (Expense)	19.08	20.06	24.08	20.76	3.42	-1.89
Pretax Income	63.94	65.7	58.45	-19.91	-44.27	-41.97
Provision for Income Taxes	-67.2	-79.73	4.94	1.25	0.61	0.07
Net Income	131.14	145.42	53.51	-21.15	-44.88	-42.04
Net Income to Common	131.14	145.42	53.51	-21.15	-44.88	-42.04
Net Income Growth	97.18%	171.77%	-	-	-	-
Shares Outstanding (Basic)	29	29	30	29	28	27
Shares Outstanding (Diluted)	29	30	31	29	28	27
Shares Change (YoY)	-4.16%	-2.57%	4.24%	4.38%	2.97%	4.56%
EPS (Basic)	4.53	4.95	1.80	-0.72	-1.60	-1.54
EPS (Diluted)	4.49	4.89	1.75	-0.72	-1.60	-1.54
EPS Growth	106.91%	179.43%	-	-	-	-
Shares Outstanding	28.8	28.58	29.74	29.56	29.01	27.42
Free Cash Flow	96.71	78.48	91.12	1.02	2.47	-24.79
Free Cash Flow Growth	23.23%	-13.88%	8798.73%	-58.59%	-	-
Free Cash Flow Per Share	3.31	2.64	2.98	0.03	0.09	-0.91
Gross Margin	85.78%	85.39%	84.68%	84.54%	83.79%	85.74%
Operating Margin	5.61%	5.59%	4.49%	-6.45%	-11.67%	-17.07%
Profit Margin	14.33%	15.95%	6.67%	-3.39%	-11.00%	-18.01%
FCF Margin	10.57%	8.61%	11.35%	0.16%	0.61%	-10.62%
EBITDA	67.34	64.91	42.63	-37.43	-45.73	-38.63
EBITDA Margin	7.36%	7.12%	5.31%	-5.99%	-11.21%	-16.55%
EBIT	51.32	50.95	36.08	-40.27	-47.59	-39.85
EBIT Margin	5.61%	5.59%	4.49%	-6.45%	-11.67%	-17.07%
Effective Tax Rate	-105.11%	-121.35%	8.46%	-6.26%	-1.38%	-0.17%

Updated May 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q